Form 4: SHF Holdings CMO Jeffrey Kay Acquires Series B Stock

Chief Marketing Officer Jeffrey R. Kay acquired 63 shares of Series B Convertible Preferred Stock and 4,057 warrants in a late-reported transaction.

Summary

• Jeffrey R. Kay, the Chief Marketing Officer, purchased 63 shares of Series B Convertible Preferred Stock on September 30, 2025.
• The acquisition included 4,057 Series B Warrants to purchase common stock at an exercise price of $7.7644.
• The preferred stock was purchased at a price of $800.00 per share.
• Shareholder approval for this specific transaction was granted on November 6, 2025.
• The company redeemed two shares of the preferred stock in December 2025, leaving the reporting person with 61 shares.
• This disclosure was filed significantly late due to an administrative oversight.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as neutral; while insider buying is typically positive, the extreme delay in reporting and the immediate redemption of shares suggest administrative friction and complex capital structures.

Positives

• Direct insider investment by the Chief Marketing Officer signals confidence in the company's long-term value.
• The transaction was conducted at a substantial price of $800 per preferred share.
• Shareholder approval was successfully obtained for the issuance of these securities.

Negatives

• The transaction was reported over seven months late, indicating a failure in internal compliance and reporting procedures.
• The company has already begun redeeming the preferred shares, which utilizes cash reserves.
• The conversion price of $7.7644 may represent a significant discount depending on the prevailing market price of common stock.

Risks

• Potential dilution of common shareholders if the 61 remaining preferred shares and 4,057 warrants are converted or exercised.
• Regulatory risk associated with the late filing of Section 16 reports.
• Liquidity risk if the company is required to continue redeeming preferred shares under the Certificate of Designation.

Future Outlook

The issuance of convertible preferred stock and warrants suggests the company is utilizing structured financing from insiders to manage capital needs, with potential for future dilution upon conversion.

Management Comments

• This transaction is being reported late due to an inadvertent administrative oversight.

Industry Context

StockSavvy.ai notes that insider participation in private placements is a common strategy for micro-cap companies in the cannabis-related financial services sector to secure funding when traditional capital markets are restrictive.

Comparison to Industry Standards

• The use of convertible preferred instruments with attached warrants is a standard financing structure for growth-stage companies.
• The late filing of a Form 4 is a deviation from standard SEC compliance expectations, which typically require reporting within two business days.

Corporate Governance

Related Party Transactions

• Jeffrey R. Kay, an officer of the company, purchased securities directly from the Issuer under a Securities Purchase Agreement.

Stakeholder Impact

• Common shareholders may experience dilution if the preferred stock is converted at the $7.7644 price point.
• The company's cash position was briefly improved by the $800 per share purchase price, though partially offset by subsequent redemptions.

Next Steps

• Monitor for further redemptions of the remaining 61 shares of Series B Preferred Stock.
• Watch for the potential exercise of the 4,057 warrants starting from May 11, 2026.

Key Dates

Recommendation

The insider investment is a positive signal of commitment, but the small scale of the transaction and the administrative delays in reporting do not provide a sufficient catalyst for a rating change.

Keywords

SHF Holdings, SHFS, Jeffrey R. Kay, Series B Preferred Stock, Warrants, Insider Buying, Convertible Securities, Cannabis Finance